Andrew Kenneth William Powell
VP, G. Counsel and Corp. Sec., COLLAGENEX PHARMACEUTICALS INC.
Companies
- Aclaris Therapeutics, Inc.Board member Jan 26, 2017 to Jun 4, 20241
- Silverback TherapeuticsBoard member Dec 3, 2020 to Jun 13, 20222
- LIFECORE BIOMEDICAL, INC. \DE\Board member Oct 22, 2018 to Jun 7, 20223
- MedivationGeneral counsel May 29, 2015 to Sep 30, 20164
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- LIFECORE BIOMEDICAL, INC. \DE\ LFCR27,477 shares5$176.1K at $6.41Jun 4, 2022
- Aclaris Therapeutics, Inc. ACRS33,523 shares6$113.3K at $3.38Jun 1, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 1, 2024Exercised options 4,660 shares of Aclaris Therapeutics, Inc.6
- Mar 4, 2024Bought 6,000 shares at $1.25 of Aclaris Therapeutics, Inc.7
- Mar 1, 2024Bought 8,500 shares at $1.23 of Aclaris Therapeutics, Inc.7
- Jun 2, 2023Exercised options 4,507 shares of Aclaris Therapeutics, Inc.8
- Nov 8, 2022Gift 4,000 shares of Aclaris Therapeutics, Inc.9
- Jun 4, 2022Granted 7,059 shares at $9.50 of LIFECORE BIOMEDICAL, INC. \DE\5
- Jun 3, 2022Exercised options 3,356 shares of Aclaris Therapeutics, Inc.10
- May 16, 2022Gift 709 shares of Aclaris Therapeutics, Inc.10
- Nov 23, 2021Gift 5,500 shares of Aclaris Therapeutics, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARMedivation, General counsel
- 5
- 6
- 7SEC EDGARForm 4 filed Mar 5, 2024
- 8SEC EDGARForm 4 filed Jun 5, 2023
- 9SEC EDGARForm 4 filed Jan 20, 2023
- 10SEC EDGARForm 4 filed Jun 6, 2022
- 11SEC EDGARForm 4 filed Dec 3, 2021